Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers (NCT03452332) | M.D. Anderson Cancer Center | 2018-07-18 |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
Track Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.